Bone marrow-derived endothelial progenitor cells for advanced liver cirrhosis

The aim of this study is to evaluate the safety and therapeutic effects of autologous bone marrow-derived endothelial progenitor cells, when administered through the hepatic artery of patients with advanced liver cirrhosis.